Recurrent Head and Neck Cancer

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00002	Cetuximab	1	Completed	1
DB16956	L-Acetylleucine	1	Completed	1
DB01204	Mitoxantrone	1	Completed	1
DB12655	Patidegib	1	Completed	1
DB01101	Capecitabine	1 / 2	Terminated	1
DB01073	Fludarabine	1 / 2	Recruiting	1
DB09035	Nivolumab	1 / 2	Terminated	1
DB09037	Pembrolizumab	1 / 2	Terminated	1
DB14722	ADU-S100	2	Terminated	1
DB00290	Bleomycin	2	Terminated	1
DB17465	CD-16 NK-92 cells	2	Recruiting	1
DB06772	Cabazitaxel	2	Completed	1
DB00002	Cetuximab	2	Active Not Recruiting	1
DB00002	Cetuximab	2	Recruiting	1
DB00515	Cisplatin	2	Unknown Status	1
DB01248	Docetaxel	2	Unknown Status	1
DB11714	Durvalumab	2	Active Not Recruiting	1
DB17253	Fimaporfin	2	Terminated	1
DB16479	Inbakicept	2	Recruiting	1
DB09037	Pembrolizumab	2	Active Not Recruiting	2
DB09037	Pembrolizumab	2	Recruiting	2
DB09037	Pembrolizumab	2	Terminated	1
DB05578	Ramucirumab	2	Recruiting	1
DB15140	Bempegaldesleukin	2 / 3	Terminated	1
DB09037	Pembrolizumab	2 / 3	Terminated	1
DB00958	Carboplatin	3	Completed	1
DB00002	Cetuximab	3	Completed	1
DB00515	Cisplatin	3	Completed	1
DB01248	Docetaxel	3	Terminated	1
DB00544	Fluorouracil	3	Completed	1
DB00317	Gefitinib	3	Terminated	1
DB09037	Pembrolizumab	3	Completed	1